Increased levels of Dickkopf-1 are indicative of Wnt/β-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density

Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis

(2015) C. Tsentidis et al.   OSTEOPOROSIS INTERNATIONAL

Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density

(2015) Charalampos Tsentidis et al.   PEDIATRIC DIABETES

Plasma and vitreous fluid levels of Dickkopf-1 in patients with diabetic retinopathy

(2014) F Qiu et al.   EYE

Relationship of Dickkopf1 (DKK1) with Cardiovascular Disease and Bone Metabolism in Caucasian Type 2 Diabetes Mellitus

(2014) Antonia Garcia-Martín et al.   PLoS One

Circulating Dickkopf‐1 in Diabetes Mellitus: Association With Platelet Activation and Effects of Improved Metabolic Control and Low‐Dose Aspirin

(2014) Stefano Lattanzio et al.   Journal of the American Heart Association

High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment

(2013) Giacomina Brunetti et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus

(2013) Agostino Gaudio et al.   Diabetes & Vascular Disease Research

Diabetes, Biochemical Markers of Bone Turnover, Diabetes Control, and Bone

(2013) Jakob Starup-Linde   Frontiers in Endocrinology

Plasma Dickkopf1 (DKK1) Concentrations Negatively Associate with Atherosclerotic Calcified Plaque in African-Americans with Type 2 Diabetes

(2012) Thomas C. Register et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation

(2010) Joseph S Butler et al.   BMC MUSCULOSKELETAL DISORDERS

Alterations of the Wnt/β-catenin pathway and its target genes for the N- and C-terminal domains of parathyroid hormone-related protein in bone from diabetic mice

(2010) S. Portal-Núñez et al.   FEBS LETTERS

Biphasic Glucocorticoid-Dependent Regulation of Wnt Expression and Its Inhibitors in Mature Osteoblastic Cells

(2009) Wendy Mak et al.   CALCIFIED TISSUE INTERNATIONAL

The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis

(2009) Athanasios D. Anastasilakis et al.   CLINICAL ENDOCRINOLOGY

Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis

(2009) B. Gustafson et al.   DIABETOLOGIA

Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo

(2009) Hong Y. Choi et al.   PLoS One

The Binding Between Sclerostin and LRP5 is Altered by DKK1 and by High-Bone Mass LRP5 Mutations

(2008) Wendy Balemans et al.   CALCIFIED TISSUE INTERNATIONAL

Osteoporosis among patients with type 1 and type 2 diabetes

(2008) A. Räkel et al.   DIABETES & METABOLISM

Signal transduction and transcriptional regulation during mesenchymal cell differentiation

(2008) Riko Nishimura et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Runt-Related Transcription Factor 2 (RUNX2) and RUNX2-Related Osteogenic Genes Are Down-Regulated throughout Osteogenesis in Type 1 Diabetes Mellitus

(2007) John L. Fowlkes et al.   ENDOCRINOLOGY